Fig. 2From: Research priorities for therapeutic plasma exchange in critically ill patientsSchematic illustration of potential (explorative) targets for replacement and removal by plasma exchange (adjusted from [99]). DAMPs damage associated molecular patterns, VWF von Willebrand factor, ULVWM ultralarge von Willebrand multimers, Angpt-1/-2 angiopoietin, VEGF vascular endothelial growth factor, Hpa-1/-2 heparanase, ATIII antithrombin III, ADAMTS13 A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13Back to article page